Brain Tumor Awareness Month Glioblastoma(GBM) Key Opinion Leader(KOL) Webinar

This webinar features two leading experts in GBM and brain cancer treatment and research, John Laterra, M.D., Ph.D. and Matthias Holdhoff, M.D., Ph.D., and our Chief Scientific Officer Kishor Bhatia, Ph.D. During the webinar, our experts discuss the current treatment landscape of GBM, challenges facing GBM patients, and the potential of Lantern’s drug candidate LP-184 for GBM as well as other brain cancers.
About our Key Opinion Leaders:
John Laterra, M.D., Ph.D. - Director of the Brain Cancer Program and Director of the Division of Neuro-Oncology at Johns Hopkins School of Medicine
Matthias Holdhoff, M.D., Ph.D. - Medical neuro-oncologist in the Brain Cancer Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and associate professor of oncology and neurological surgery at Johns Hopkins University School of Medicine
#Glioblastoma #CancerAwareness #Oncology